FDA-approved FGFR inhibitors show promise against rare and aggressive pediatric brain tumor

Published Date: 27 May 2025

A study led by researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center and the Broad Institute of MIT and Harvard has uncovered critical insights into the biology of embryonal tumor with multilayered ...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer patients with HIV have demonstrated safety with immune checkpoint inhibitors.

2.

FDA-approved FGFR inhibitors show promise against rare and aggressive pediatric brain tumor

3.

iPSC-based vaccines: A new hope for preventing and treating colorectal cancer

4.

Study sets benchmark for treatment of advanced cervical cancer

5.

Racial differences seen in epigenetic age acceleration in childhood cancer survivors


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot